QQ客服 官方微博 反馈留言

	Early BCR-ABL1 decline in imatinib-treated patients with chronic myeloid leukemia: results from a multicenter study of the Chinese CML alliance
	Zhang, JR; Wang, YQ; Wang, JX; Hu, JD; Chen, SN; Jin, J; Liu, T; Zhou, JF; Hu, Y; Ma, DX
刊名	Blood Cancer Journal
	2018
卷号	Vol.8
ISSN号	2044-5385
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/1843748
专题	四川大学
作者单位	1.Chinese Acad Med Sci, Blood Dis Hosp, Tianjin, Peoples R China 2.Fujian Med Univ Union Hosp, Fujian Inst Hematol, Fujian Prov Key Lab Hematol, Fuzhou, Fujian, Peoples R China 3.Chinese Acad Med Sci, Inst Hematol, Tianjin, Peoples R China 4.Shandong Univ, Qilu Hosp, Dept Hematol, Jinan, Shandong, Peoples R China 5.Peking Union Med Coll, Tianjin, Peoples R China 6.Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Hematol, Wuhan, Hubei, Peoples R China 7.Peking Univ, Inst Hematol, Peoples Hosp, Beijing, Peoples R China 8.Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Inst Hematol, Wuhan, Hubei, Peoples R China 9.Soochow Univ, Jiangsu Inst Hematol, Affiliated Hosp 1, Key Lab Thrombosis & Hemostasis,Minist Hlth, Suzhou, Jiangsu, Peoples R China 10.Sichuan Univ, West China Hosp, Dept Hematol, Chengdu, Sichuan, Peoples R China
推荐引用方式 GB/T 7714	Zhang, JR,Wang, YQ,Wang, JX,et al. Early BCR-ABL1 decline in imatinib-treated patients with chronic myeloid leukemia: results from a multicenter study of the Chinese CML alliance[J]. Blood Cancer Journal,2018,Vol.8.
APA	Zhang, JR.,Wang, YQ.,Wang, JX.,Hu, JD.,Chen, SN.,...&Ma, DX.(2018).Early BCR-ABL1 decline in imatinib-treated patients with chronic myeloid leukemia: results from a multicenter study of the Chinese CML alliance.Blood Cancer Journal,Vol.8.
MLA	Zhang, JR,et al."Early BCR-ABL1 decline in imatinib-treated patients with chronic myeloid leukemia: results from a multicenter study of the Chinese CML alliance".Blood Cancer Journal Vol.8(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。